48.10
-0.82%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ever Fortune. AI Co
Its shares trade on Taipei Exchange under the ticker 6841.TWO. It has been listed since 14 September 2021. In the fiscal year to 31 December 2025, it reported revenue of TWD 378.8m and net income of TWD 83.4m. At that date it held total assets of TWD 2.12bn and shareholders' equity of TWD 1.68bn.
Ever Fortune.AI Co., Ltd. engages in the provision of artificial intelligence (AI) tools in medical field. The company is headquartered in Taichung, Taichung. The company went IPO on 2021-09-14. AI Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical artificial intelligence software related products. The firm mainly provides medical big data and cloud biomedical platform, medical artificial intelligence (AI) technology solutions. The firm provides medical artificial intelligence data, analysis technology and services, and customized medical AI technology solutions. The firm's products include radiographic bone age-assisted interpretation and height prediction system, ultrasound breast tumor auxiliary classification system, computer tomography liver cancer metastasis risk management system, liver fibrosis evaluation system, and irregular cardiac fibrillation interpretation.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 14 Sept 2021
- Employees
- 74
- Website
- everfortuneai.com.tw ↗
Leadership
Pay as last reported
- Mingfeng ChenChairman of the Board, since 2023
- Wending LinFinance Manager, Corporate Governance Officer
- Guowei XuChief Information Officer, since 2022
- Youzheng LiGeneral Manager, Director, since 2023
- Changmin LinChief Information Security Officer
- Nengyi ShiDirector
- Ms. Su-Chi WangDirector
- Yaofang XieDirector
- Yili ZhengDirector
- Wenhuan ZhuoDirector
- Hsuan-Shu LeeIndependent Director
- Chongji LiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ever Fortune.AI provides medical AI tools for radiographic bone age assessment and ultrasound breast tumor classification.
- The company offers cloud biomedical platforms and AI solutions for medical big data analysis.
- Ever Fortune.AI develops customized medical AI technology solutions for healthcare providers.
Weaknesses
- Ever Fortune.AI has 74 employees, which is a small workforce for a medical AI company.
- The company's IPO was on 14 September 2021, indicating limited market history.
- Ever Fortune.AI is based in Taichung, Taiwan, which may limit global reach.
Opportunities
- Taiwan's Health Care sector offers growth potential for medical AI solutions.
- The global Health Care industry is expanding, creating demand for AI tools.
- Ever Fortune.AI can expand into new medical AI applications like liver cancer metastasis management.
Threats
- The Health Care industry faces regulatory challenges in medical AI applications.
- Competition from larger AI firms in the Health Care sector is increasing.
- Ever Fortune.AI's small size may hinder its ability to compete with bigger companies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.